InvestorsHub Logo
Followers 9
Posts 402
Boards Moderated 0
Alias Born 04/22/2013

Re: trding post# 20938

Thursday, 03/22/2018 6:37:36 PM

Thursday, March 22, 2018 6:37:36 PM

Post# of 233563
trding:
Gotta say I'm really getting pumped up about the R/S. Finally some action and accompanying data for shareholders- and only weeks away. I think we'll be just fine.

Noticed that ARNA made another public offering yesterday of 8.5 million shares at $41.50 - trying to raise $350 million. This from a company that was dead in the water a number of times and latest bit of hysteria is fueled by decent PH II results for colitis therapy.

It helps them that Celegene's potential blockbuster "ozanimod" which was the subject of $7.2 billion buy-out of Receptos in 2015 and considered a
$1 billion annual asset just had it's application for same treatment kicked back by FDA. Ouch-

And ABBV really took it on the chin today after it's $10 billion Rova-T program posted poor mid stage results for small cell lung cancer treatment and they'll have to reevaluate the entire project. They paid $5.8 billion for little known Stemcentrx and got burned-

It's as wild, crazy & out of control in the biotech arena as ever. If CYDY can show promising or better results, could take off like a rocket ship
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News